Your browser doesn't support javascript.
loading
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.
Morieri, Mario Luca; Shah, Hetal S; Sjaarda, Jennifer; Lenzini, Petra A; Campbell, Hannah; Motsinger-Reif, Alison A; Gao, He; Lovato, Laura; Prudente, Sabrina; Pandolfi, Assunta; Pezzolesi, Marcus G; Sigal, Ronald J; Paré, Guillaume; Marcovina, Santica M; Rotroff, Daniel M; Patorno, Elisabetta; Mercuri, Luana; Trischitta, Vincenzo; Chew, Emily Y; Kraft, Peter; Buse, John B; Wagner, Michael J; Cresci, Sharon; Gerstein, Hertzel C; Ginsberg, Henry N; Mychaleckyj, Josyf C; Doria, Alessandro.
Afiliação
  • Morieri ML; Research Division, Joslin Diabetes Center, Boston, MA.
  • Shah HS; Department of Medicine, Harvard Medical School, Boston, MA.
  • Sjaarda J; Department of Medicine, University of Padova, Padova, Italy.
  • Lenzini PA; Research Division, Joslin Diabetes Center, Boston, MA.
  • Campbell H; Department of Medicine, Harvard Medical School, Boston, MA.
  • Motsinger-Reif AA; McMaster University and Population Health Research Institute, Hamilton, Ontario, Canada.
  • Gao H; Department of Genetics, Washington University School of Medicine, St. Louis, MO.
  • Lovato L; Department of Genetics, Washington University School of Medicine, St. Louis, MO.
  • Prudente S; Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Pandolfi A; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Durham, NC.
  • Pezzolesi MG; Research Division, Joslin Diabetes Center, Boston, MA.
  • Sigal RJ; Department of Medicine, Harvard Medical School, Boston, MA.
  • Paré G; Wake Forest School of Medicine, Winston Salem, NC.
  • Marcovina SM; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Rotroff DM; Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio," Chieti, Italy.
  • Patorno E; Division of Nephrology and Hypertension and Diabetes and Metabolism Center, University of Utah, Salt Lake City, UT.
  • Mercuri L; Departments of Medicine, Cardiac Sciences, and Community Health Sciences, Cumming School of Medicine, Faculties of Medicine and Kinesiology, University of Calgary, Calgary, Alberta, Canada.
  • Trischitta V; McMaster University and Population Health Research Institute, Hamilton, Ontario, Canada.
  • Chew EY; Department of Medicine, University of Washington, and Northwest Lipid Metabolism and Diabetes Research Laboratories, Seattle, WA.
  • Kraft P; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.
  • Buse JB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Wagner MJ; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Cresci S; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Gerstein HC; Department of Experimental Medicine, "Sapienza" University, Rome, Italy.
  • Ginsberg HN; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD.
  • Mychaleckyj JC; Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Doria A; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
Diabetes ; 69(4): 771-783, 2020 04.
Article em En | MEDLINE | ID: mdl-31974142
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Polimorfismo de Nucleotídeo Único / PPAR alfa / Diabetes Mellitus Tipo 2 / Dislipidemias / Hipolipemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Marrocos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Polimorfismo de Nucleotídeo Único / PPAR alfa / Diabetes Mellitus Tipo 2 / Dislipidemias / Hipolipemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Marrocos País de publicação: Estados Unidos